Methylation of the O(6)-Methylguanine-DNA methyltransferase (MGMT) promoter is predictive for treatment response in glioblastoma patients. However, precise predictive cutoff values to distinguish “MGMT methylated…

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...